RxDoctor Payments Data

Kathleen Devine

Reproductive Endocrinology · Washington, DCNPI 1831380435

Payments from drug & device makers

$457,242in general payments, 2019–2025

Across 56 payments — averaging $8165.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • IBSA Institut Biochimique SA$404K
  • Ferring Pharmaceuticals AS$28K
  • Ferring Pharmaceuticals Inc.$16K
  • EMD Serono, Inc.$7K
  • Granata Bio Corporation$1K
  • Intuitive Surgical$446
  • plus $358 from 3 others

What the payments were for

  • Consulting fees$36,42467%
  • Travel & lodging$15,41028%
  • Food & beverage$2,3484%
  • Education$100%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
IBSA Institut Biochimique SA7$403,721
Ferring Pharmaceuticals AS11$28,437
Ferring Pharmaceuticals Inc.23$15,940
EMD Serono, Inc.8$7,160
Granata Bio Corporation3$1,180
Intuitive Surgical1$446
Vitrolife Inc.1$129
Myovant Sciences Inc.1$125
Coopersurgical, Inc.1$104

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few reproductive endocrinology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Other reproductive endocrinology in Washington

Where these figures come from

Is this you, or does something look wrong? →